Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy

NCT00228969 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Refractory Epilepsy

Interventions

DRUG: RWJ-333369

Sponsor

SK Life Science, Inc.